Want to see BOLD full AI Analyst Report?
Boundless Bio Inc. (BOLD) Ratios
54 Followers
Boundless Bio Inc. Ratios
BOLD's free cash flow for Q2 2026 was $-21.01M. For the 2026 fiscal year, BOLD's free cash flow was decreased by $-38.00K and operating cash flow was $-20.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.74 | 18.98 | 13.27 | 8.80 | 19.28 |
| Quick Ratio | 8.74 | 18.98 | 13.27 | 8.80 | 19.28 |
| Cash Ratio | 1.43 | 3.27 | 2.53 | 1.42 | 8.87 |
| Solvency Ratio | -0.98 | -1.15 | -0.19 | -0.28 | -0.16 |
| Operating Cash Flow Ratio | -3.72 | -7.48 | -5.01 | -5.12 | -6.01 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 51.21M | $ 98.62M | $ -132.77M | $ -90.49M | $ -77.34M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.23 | 0.02 | 0.07 | 0.00 |
| Debt-to-Equity Ratio | 0.50 | 0.32 | -0.02 | -0.06 | -0.01 |
| Debt-to-Capital Ratio | 0.33 | 0.24 | -0.02 | -0.07 | -0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.59 | 1.37 | -1.02 | -0.94 | -2.98 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.19 | 2.80 | 0.10 | 0.23 | 0.02 |
| Net Debt to EBITDA | -0.55 | -0.33 | 0.40 | 0.13 | 1.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 91.57% | 89.21% | 90.21% | 98.78% | 99.64% |
| Return on Assets (ROA) | -37.05% | -31.67% | -38.06% | -59.74% | -22.17% |
| Return on Equity (ROE) | -58.99% | -43.39% | 38.90% | 56.19% | 66.01% |
| Return on Capital Employed (ROCE) | -43.97% | -36.95% | -45.46% | -67.25% | -23.03% |
| Return on Invested Capital (ROIC) | -43.03% | -36.95% | -44.65% | -65.05% | -22.95% |
| Return on Tangible Assets | -37.05% | -31.67% | -38.06% | -59.74% | -22.17% |
| Earnings Yield | -216.89% | -132.71% | -22228184.63% | -20639557.85% | -11335771.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.84 | 0.85 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -435.02 | -428.19 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 435.02 | 428.19 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.09 | -3.58 | -2.11 | -1.78 | -1.05 |
| Free Cash Flow Per Share | -2.11 | -3.73 | -2.14 | -1.83 | -1.14 |
| Dividend Paid and CapEx Coverage Ratio | -85.46 | -23.99 | -74.02 | -37.14 | -11.43 |
| Capital Expenditure Coverage Ratio | -85.46 | -23.99 | -74.02 | -37.14 | -11.43 |
| Operating Cash Flow Coverage Ratio | -0.95 | -1.28 | -21.35 | -7.64 | -61.67 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -175.94% | -128.67% | -21353158.39% | -18283821.73% | -11368146.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.46 | -0.75 | -0.00 | -0.00 | -0.00 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.27 | 0.33 | -0.00 | -0.00 | -0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.57 | -0.78 | -0.00 | -0.00 | -0.00 |
| Price-to-Operating Cash Flow Ratio | -0.58 | -0.81 | -0.00 | -0.00 | -0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.01 | -0.00 | -0.00 | 0.00 |
| Enterprise Value Multiple | -1.02 | -1.09 | 0.40 | 0.13 | 1.38 |
| Enterprise Value | 58.00M | 70.30M | -21.51M | -5.77M | -33.91M |
| EV to EBITDA | -1.02 | -1.09 | 0.40 | 0.13 | 1.38 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -1.23 | -1.11 | 0.45 | 0.14 | 1.34 |
| EV to Operating Cash Flow | -1.24 | -1.16 | 0.46 | 0.15 | 1.46 |
| Tangible Book Value Per Share | 4.41 | 8.87 | -5.71 | -3.67 | -1.72 |
| Shareholders’ Equity Per Share | 4.41 | 8.87 | -5.71 | -3.67 | -1.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -2.60 | -3.85 | -2.22 | -2.06 | -1.13 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.90 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.80 | 0.93 | 0.95 | 0.86 | 0.92 |
Currency in USD
